Point-of-care blood test for ketones in patients with diabetes: Primary care diagnostic technology update

British Journal of General Practice

Volumn 61, Issue 589, 2011, Pages 530-531

  Plüddemann, Annette ^a   Heneghan, Carl ^a   Price, Christopher P ^a   Wolstenholme, Jane ^a   Thompson, Matthew ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Cumbria and Lancashire Pathology Commissioning Network   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; KETONE;

BLOOD GLUCOSE MONITORING; COST EFFECTIVENESS ANALYSIS; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; ECONOMIC ASPECT; EMERGENCY WARD; ENZYME CHEMISTRY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETONURIA; METHODOLOGY; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT OF CARE TESTING; PRACTICE GUIDELINE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TEST STRIP; BLOOD; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; EMERGENCY HEALTH SERVICE; EVALUATION; HOSPITAL INFORMATION SYSTEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; EMERGENCY SERVICE, HOSPITAL; HUMANS; KETONES; POINT-OF-CARE SYSTEMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 80054066583     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X588600     Document Type: Short Survey

References (14)

1. Guerci B, Tubiana-Rufi N, Bauduceau B, et al. Advantages to using capillary blood betahydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes Metab 2005; 31(4 Pt 1): 401-406. (Pubitemid 41391484)
2. Bismuth E, Laffel L. Can we prevent diabetic ketoacidosis in children? Pediatr Diabetes 2007; 8(Suppl 6): 24-33. (Pubitemid 47323764)
3. Patterson CC, Dahlquist GG, Gyürüs E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-2020: a multicentre prospective registration study. Lancet 2009; 373(9680): 2027-2033.
4. Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetesmellitus: clinical and biochemical differences. Arch Intern Med 2004; 164(17): 1925-1931. (Pubitemid 39274364)
5. Wang ZH, Kihl-SelstamE, Eriksson JW. Ketoacidosis occurs in both Type 1 and Type 2 diabetes-a population-based study from Northern Sweden.Diabet Med 2008; 25(7): 867-870.
6. Henriksen OM, Røder ME, Prahl JB, et al. Diabetic ketoacidosis in Denmark Incidence andmortality estimated frompublic health registries.Diabetes Res Clin Pract 2007; 76(1): 51-56. (Pubitemid 46240357)
7. Rewers A, McFann K, Chase HP. Bedside monitoring of blood beta-hydroxybutyrate levels in themanagement of diabetic ketoacidosis in children.Diabetes Technol Ther 2006; 8(6): 671-676. (Pubitemid 44871497)
8. Taboulet P, Haas L, Porcher R, et al. Urinary acetoacetate or capillary betahydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department setting. Eur J Emerg Med 2004; 11(5): 251-258.
9. Taboulet P, Deconinck N, Thurel A, et al. Correlation between urine ketones (acetoacetate) and capillary blood ketones (3- beta-hydroxybutyrate) in hyperglycaemic patients.Diabetes Metab 2007; 33(2): 135-139. (Pubitemid 46561387)
10. Bektas F, Eray O, Sari R, Akbas H. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res 2004; 30(3): 395-402. (Pubitemid 39453087)
11. NaunheimR, Jang TJ, Banet G, et al. Pointof- care test identifies diabetic ketoacidosis at triage. Acad Emerg Med 2006; 13(6): 683-685. (Pubitemid 43744540)
12. Voulgari C, Tentolouris N. The performance of a glucose-ketonemeter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room.Diabetes Technol Ther 2010; 12(7): 529-535.
13. Byrne HA, Tieszen KL, Hollis S, et al. Evaluation of an electrochemical sensor for measuring blood ketones.Diabetes Care 2000; 23(4): 500-503. (Pubitemid 30185794)
14. Laffel LM,Wentzell K, Loughlin C, et al. Sick daymanagement using blood 3- hydroxybutyrate (3-OHB) compared with urine ketonemonitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.Diabet Med 2006; 23(3): 278-284.